Opioid Sparing Techniques for Colorectal Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests different pain relief methods for individuals undergoing surgery for colorectal cancer, aiming to determine which method enables patients to start chemotherapy sooner. It compares three approaches: administering morphine directly into the spine (Intrathecal Morphine Block) and two types of numbing injections near the abdomen, specifically the Bilateral Quadratus Lumborum Block and the Bilateral Transverse Abdominis Plane Block. The study also examines how each method affects recovery, including bowel function and hospital stay length. Candidates include those undergoing open surgery for colorectal cancer who can read and understand the study. The goal is to reduce opioid use and improve the overall treatment experience. As an unphased trial, this study provides a unique opportunity to contribute to understanding pain management options and potentially enhance recovery experiences for future patients.
Do I need to stop taking my current medications for the trial?
The trial requires that you stop taking anticoagulants (blood thinners) at least 7 days before surgery. Other medications are not specifically mentioned, so it's best to discuss your current medications with the trial team.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Previous studies have shown different safety levels for the three treatments being explored.
Research indicates that the quadratus lumborum block is generally safe when performed with ultrasound guidance, which helps avoid complications by accurately targeting the nerves. Studies suggest it effectively reduces the need for opioids during surgeries.
The transverse abdominis plane (TAP) block is also considered safe, with studies reporting no serious complications. It is often used for pain relief after abdominal surgeries and is part of enhanced recovery plans.
Intrathecal morphine has been used effectively for pain management after surgery, though it can cause side effects like nausea, vomiting, and trouble urinating. These side effects are usually manageable but occur more frequently with this treatment compared to the others.
Overall, while each treatment has its safety considerations, studies have provided a reasonable expectation of safety for those considering participation in the trial.12345Why are researchers excited about this trial?
Researchers are excited about these opioid-sparing techniques for colorectal cancer because they offer alternatives to traditional pain management. Unlike standard care, which often relies heavily on opioids, these techniques aim to reduce opioid use and its associated side effects. The quadratus lumborum block and transverse abdominis plane block utilize local anesthetics to target pain at the source, potentially leading to more effective pain relief with fewer systemic effects. Meanwhile, the intrathecal morphine block delivers morphine directly into the spinal fluid, allowing for lower doses and minimizing systemic exposure. These approaches not only promise enhanced pain control but also a reduction in opioid-related complications, which is a significant advancement in postoperative care.
What evidence suggests that this trial's treatments could be effective for colorectal cancer?
This trial will compare different opioid-sparing techniques for managing pain after colorectal cancer surgery. Participants may receive an intrathecal morphine block, which research has shown can effectively manage pain and reduce the need for other painkillers, leading to fewer complications and faster recovery. Another group will receive a quadratus lumborum block, which studies indicate can lessen pain and the use of painkillers after surgery, aiding in recovery and maintaining stable blood flow. Additionally, some participants will undergo a transverse abdominis plane block, which has been proven to decrease pain after surgery and shorten hospital stays. Overall, these treatments aim to manage pain effectively and reduce side effects related to painkillers.36789
Are You a Good Fit for This Trial?
This trial is for individuals with colorectal cancer who are undergoing surgery and need pain management. They aim to see if certain pain control methods can help patients start chemotherapy sooner after surgery.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Preoperative
Participants receive either intrathecal morphine, quadratus lumborum block, or transversus abdominis plane block in a preoperative setting
Postoperative
Participants are monitored for return of bowel function, opioid-related adverse events, and pain management
Follow-up
Participants are monitored for safety and effectiveness after treatment, including time to initiation of chemotherapy
What Are the Treatments Tested in This Trial?
Interventions
- Bilateral Quadratus Lumborum Block
- Bilateral Transverse Abdominis Plane Block
- Intrathecal Morphine Block
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Tennessee Graduate School of Medicine
Lead Sponsor